Arrowgrass Capital Partners (US)’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-155,000
Closed -$6.36M 373
2018
Q4
$6.36M Buy
155,000
+153,450
+9,900% +$6.58M 0.24% 118
2018
Q3
$7.24M Sell
1,550
-153,450
-99% -$7.01M 0.22% 112
2018
Q2
$6.76M Buy
+155,000
New +$7.23M 0.23% 104
2017
Q3
Sell
-1,077
Closed -$5.27M 604
2017
Q2
$5.27M Hold
1,077
0.04% 378
2017
Q1
$5.07M Buy
1,077
+212
+25% +$10.1K 0.05% 330
2016
Q4
$4.16M Buy
865
+610
+239% +$28K 0.05% 281
2016
Q3
$1.01M Hold
255
0.01% 363
2016
Q2
$904K Hold
255
0.01% 346
2016
Q1
$997K Hold
255
0.01% 316
2015
Q4
$1.09M Sell
255
-336
-57% -$14.8K 0.01% 304
2015
Q3
$2.48M Sell
591
-1,162
-66% -$54.3K 0.05% 235
2015
Q2
$8.75M Buy
1,753
+1,018
+139% +$48.2K 0.13% 148
2015
Q1
$3.31M Buy
+735
New +$33K 0.05% 203

Other funds holding MET

Arrowgrass Capital Partners (US)'s MET Position: Q4 2019 in Review

Arrowgrass Capital Partners (US) sold out of MetLife (MET) in Q4 2019, closing a stake of 143,941 shares — an estimated $6.79M sold.

Arrowgrass Capital Partners (US) first reported a position in MET in Q3 2015 and held it in 15 quarters. The position peaked at $12.1M in Q2 2017. 1,114 funds tracked by Wall St. Rank hold MET as of Q4 2019.

  • Arrowgrass Capital Partners (US) reported no remaining MetLife position as of Q4 2019 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 143,941 MetLife shares in Q4 2019, an estimated $6.79M.
  • Arrowgrass Capital Partners (US) first reported a position in MetLife in Q3 2015 and held it in 15 quarters.
  • Arrowgrass Capital Partners (US)'s MetLife position peaked at $12.1M in Q2 2017.
  • 1,114 funds tracked by Wall St. Rank held MetLife as of Q4 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q4 2019, filed 14 Feb 2020.